Table 2.
TNM stage | Compliers (n=1499) | Non-compliers (n=361) | P value* | ||
Number | % | Number | % | ||
All CRCs | |||||
I | 695 | 46.4 | 176 | 48.8 | 0.46 |
II | 339 | 22.6 | 86 | 23.8 | |
III | 387 | 25.8 | 79 | 21.9 | |
IV | 78 | 5.2 | 20 | 5.5 | |
Total | 1499 | 100 | 361 | 100 | |
CRCs diagnosed within 1 year of the positive FIT | |||||
I | 678 | 46.8 | 143 | 57.0 | 0.014 |
II | 324 | 22.3 | 51 | 20.3 | |
III | 373 | 25.7 | 46 | 18.3 | |
IV | 75 | 5.2 | 11 | 4.4 | |
Total | 1450 | 100 | 251 | 100 | |
CRCs diagnosed after 1 year of the positive FIT | |||||
I | 17 | 34.7 | 33 | 30.0 | 0.90 |
II | 15 | 30.6 | 35 | 31.8 | |
III | 14 | 28.6 | 33 | 30.0 | |
IV | 3 | 6.1 | 9 | 8.2 | |
Total | 49 | 100 | 110 | 100 |
*Comparison between cohorts through the χ2 test.
CRCs, colorectal cancers; FIT, faecal immunochemical test; TNM, tumour, node, metastases.